Trials / Completed
CompletedNCT01682577
Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition
Bioequivalence Study of 4 mg Perindopril Tablets Produced by PT Dexa Medica in Comparison With the Reference Tablets (Prexum® 4 mg, Servier)Under Fasting Condition
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Dexa Medica Group · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to find out whether the bioavailability of PT Dexa Medica's formulation of 4 mg perindopril tert-butylamine tablets was equivalent to that of the innovator's product (Prexum® 4 mg, Servier).
Detailed description
The participating subjects were required to have an overnight fast and in the next morning were given orally one tablet of the test drug (Perindopril 4 mg tablets of PT Dexa Medica) or one tablet of the reference drug (Prexum® 4 mg, Servier). Blood samples were drawn immediately before taking the drug (control), and at 20, 40 minutes, and 1, 1.5, 2, 3, 4, 6, 8, 12, 24, 48, 96, 144, 192 hours after drug administration. Three weeks after the first drug administration (washout period), the procedure was repeated using the alternate drug. The pharmacokinetic parameters, including AUCt, AUCinf, Cmax, t max, and t1/2, were determined based on the concentrations of the perindopril parent compound and the metabolite perindoprilat, using high-performance liquid chromatography method with tandem mass spectrometry detector (LC-MS/MS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Perindopril 4 mg tablets of PT Dexa Medica | Test product was given as a single dose, under the procedure as described in the Section: Detailed description of the study. |
| DRUG | Perindopril 4 mg tablets of Servier | Reference product was given as a single dose, under the procedure as described in the Section: Detailed description of the study. |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2008-11-01
- Completion
- 2008-12-01
- First posted
- 2012-09-11
- Last updated
- 2012-09-11
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT01682577. Inclusion in this directory is not an endorsement.